03 Jul Why Serialization Isn’t Enough: The Bigger Picture of Drug Traceability

Posted at 16:44h in News by

Let’s start with the obvious: serialization is a huge step forward. If you’re in the U.S. pharmaceutical industry, you’re already familiar with the requirement to assign a unique id, usually a 2D data matrix barcode to every saleable unit of prescription drug product. It’s a key part of keeping counterfeit medications out of the supply chain and protecting patients.

But here’s the thing: serialization alone isn’t the whole story, not for DSCSA, not for safety, and definitely not for true supply chain transparency.

Think of serialization like tagging every passenger on a flight. It’s important, sure, but it doesn’t tell you where they came from, where they transferred, or what happened if they didn’t arrive. Serialization gives each product a unique ID, but tracking and verifying that ID through the entire supply chain? That’s where things get real.

To truly comply with the DSCSA by November 27, 2024, pharmaceutical companies needed full end-to-end traceability. That includes:

  • T3 data exchange (Transaction Information, History, and Statement);
  • Verification systems to confirm product authenticity on request;
  • Interoperable digital systems (like EPCIS);
  • And the ability to respond to FDA or trading partner requests quickly.

The industry is quickly realizing that just printing a barcode isn’t enough. To really lock down the supply chain, we need smarter systems that can track every move a product makes.

To close the loop on traceability, the industry is moving toward EPCIS (Electronic Product Code Information Services), a global standard that allows parties to exchange serialization event data in a structured, machine-readable way.

EPCIS isn’t just another format, it’s the framework for creating a shared digital ledger of every action a drug takes: commissioned, shipped, received, sold. Think of it like a blockchain-lite, but practical and tailored for pharma.

Your ERP system should be EPCIS-ready and capable of handling complex traceability events, not just logging serials in a database.

A lot of companies are treating serialization like a checkbox: “Do we print barcodes? Yep. Cool, we’re compliant.”

But compliance isn’t about the barcode, it’s about what happens after that barcode leaves your facility.

If your ERP can’t integrate with VRS (Verification Router Service), communicate EPCIS events, automatically compile and respond to T3 requests, then you’re at serious risk of non-compliance, delays, and costly audit issues down the line.

Here’s a quick reality check for what your business needs beyond serialization:

  • A serialization engine that talks to packaging lines;
  • An ERP that can send and receive EPCIS data;
  • Audit trails and logs for every transaction event;
  • Verification tools (automated, not manual!);
  • System alerts for data gaps or suspicious activity;
  • A way to integrate trading partners.

Serialization is your ticket into the compliance game, but traceability is how you win it.

If you’re relying on spreadsheets, manual uploads, or disconnected systems, you’re not just making life harder, you’re risking penalties, supply chain interruptions, and potential patient harm.

The good news? DOit ERP is built for pharma, and designed to go far beyond serialization.

Not sure if your current setup covers it all? Let’s talk. We’d love to help you see the full picture.

Print page
0 Likes